Literature DB >> 27432035

Actinomyces meyeri, a Common Agent of Actinomycosis.

Robert Rolfe1, Lisa L Steed2, Cassandra Salgado3, J Michael Kilby4.   

Abstract

BACKGROUND: Actinomyces, particularly Actinomyces israelii, may cause indolent, persistent infections or represent normal mucosal flora, leading to management dilemmas.
MATERIALS AND METHODS: Prompted by a refractory Actinomyces meyeri infection complicating AIDS, clinical data for all Actinomyces isolates at our hospital laboratory since 1998 were analyzed.
RESULTS: A total of 140 cases had a positive result for Actinomyces cultures. Of 130 cases with adequate follow-up, 36 (28%) cases had end-organ or disseminated disease treated with prolonged antibiotics or surgery or both (Group 1). A. meyeri was more common than A. israelii (33% versus 8%; P < 0.05) in Group 1, particularly thoracic infections. Another 56 (43%) cases were considered local pathogens, treated with drainage only or short-course antibiotics (Group 2). Another 38 (29%) cases were deemed commensals (Group 3). Immunosuppression was less frequent in Group 1 versus Group 2 or 3 (P = 0.05) and human immunodeficiency virus or AIDS was uncommon. Foreign bodies or devices (Group 1 versus Group 2 or 3, P = 0.003) and alcoholism (Group 1 versus Group 2 or 3; P = 0.03) were associated with actinomycosis. Isolates from the central nervous system and musculoskeletal sites were more often treated as definitive disease; skin, abdominal or pelvic or single blood culture isolates were more likely commensals (all P < 0.05). Disease progression or recurrence did not occur in Groups 2 and 3, whereas Group 1 had complex and variable courses, including 2 deaths.
CONCLUSIONS: In the absence of disseminated or end-organ disease, avoiding prolonged therapy for Actinomyces isolates was not associated with adverse outcomes. Alcoholism or foreign bodies were associated with actinomycosis. A. meyeri may be a more common cause of actinomycosis than previously recognized.
Copyright © 2016 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Actinomyces meyeri; Actinomycosis; Clinical outcomes; Epidemiology

Mesh:

Year:  2016        PMID: 27432035     DOI: 10.1016/j.amjms.2016.03.003

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  5 in total

1.  Emerging role of Actinomyces meyeri in brain abscesses: A case report and literature review.

Authors:  Laia Jimena Vazquez Guillamet; Maricar F Malinis; Jaimie P Meyer
Journal:  IDCases       Date:  2017-07-20

2.  "Pulmonary Actinomycosis attributable to Actinomyces meyeri presenting as cardiac tamponade: a case report".

Authors:  Saori Nishizawa; Keisuke Anan; Kazunori Tobino; Masanobu Okahisa; Yuki Goto; Kojin Murakami; Takuto Sueyasu; Miyuki Munechika; Kohei Yoshimine; Mai Yoshino
Journal:  Multidiscip Respir Med       Date:  2018-06-14

3.  Species diversity and molecular analysis of opportunistic Mycobacterium, Nocardia and Rhodococcus isolated from the hospital environment in a developing country, a potential resources for nosocomial infection.

Authors:  Marzieh Siavashifar; Fatemeh Rezaei; Tahereh Motallebirad; Davood Azadi; Abdorrahim Absalan; Zahra Naserramezani; Mohadeseh Golshani; Morteza Jafarinia; Kazem Ghaffari
Journal:  Genes Environ       Date:  2021-01-28

4.  Brain Abscess: A Rare Clinical Case with Oral Etiology.

Authors:  André João da Silva Pais Rocha Pereira; Ana Teresa Tavares; Marcelo Prates; Natacha Ribeiro; Luís Filipe Fonseca; Maria do Rosário Marques; Francisco Proença
Journal:  Case Rep Infect Dis       Date:  2022-01-04

5.  Actinomyces meyeri: A Rare Cause of Postsurgical Pelvic Actinomycosis.

Authors:  C Michele Markey; Lauren E Vestal
Journal:  Case Rep Obstet Gynecol       Date:  2018-06-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.